NCT06448156

Brief Summary

Aim This was a population-based retrospective cohort study of OHCA. This study intends to retrospectively analyze the data of pre-hospital emergency system in Guangzhou for 10 years, explore the incidence trend of OHCA in Guangzhou for 10 years; Through further analysis, we try to explore the time distribution characteristics of OHCA in order to understand the epidemiological characteristics and rules of OHCA in super large cities in southern China. Methods The pre-hospital traffic data in the main urban area of Guangzhou Emergency Medical Command Center database from 2011 to 2020 were collected. The cases diagnosed as "cardiac arrest" and "sudden death" were screened, and the cases with non-cardiac causes in the diagnosis were deleted. The crude incidence rate and age-standardized incidence rate of OHCA were calculated. Joinpoint software was used to calculate the changing nodes in the OHCA incidence trend, and the AnnualPercent Change (APC) and Average AnnualPercent Change (Average AnnualPercent Change, APC) of OHCA incidence were calculated. AAPC). The OHCA data were grouped according to the six main urban areas, and the crude incidence rate, ASIR and changing trend of the six main urban areas were calculated. The data of OHCA were grouped by age, and the crude incidence rate, ASIR and changing trend of each age group were calculated. The data information was divided into groups according to 24 hours a day, 7 days a week, and four seasons. The number of OHCA cases in different time periods was statistically described. The data were imported into SPSS 26.0 for analysis, and Mann-Kendall test was used to evaluate the statistical significance of the time trend. Time rhythm variability was tested for mean distribution using chi-square goodness of fit test.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
44,375

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2021

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2021

Completed
3.4 years until next milestone

First Submitted

Initial submission to the registry

June 3, 2024

Completed
4 days until next milestone

First Posted

Study publicly available on registry

June 7, 2024

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2025

Completed
Last Updated

June 7, 2024

Status Verified

December 1, 2023

Enrollment Period

5 years

First QC Date

June 3, 2024

Last Update Submit

June 3, 2024

Conditions

Outcome Measures

Primary Outcomes (4)

  • Crude incidence rate

    The frequency of new cases of a disease in a given population over a given period of time.

    2011-01-01 to 2020-12-31

  • Age standardized incidence rate

    Incidence rates after removing the influence of age, and incidence rates normalised by age. The rationale is that age is an important influence on cancer incidence, with higher incidence rates occurring at older ages, so that if the age structure of the population in two regions is very different, it is not possible to determine whether the high incidence of a disease in a particular region is due to a different age composition or to other influences if incidence rate comparisons are applied.

    2011-01-01 to 2020-12-31

  • Average annual percentage change

    Calculated using the weighted average of the APC, it is an overall measure of trend.

    2011-01-01 to 2020-12-31

  • Annual percentage change

    Indicates the change from one year to the next within a segment at a constant percentage on a log-linear model for evaluating trends within segments.

    2011-01-01 to 2020-12-31

Study Arms (8)

0-19 years age group

Diagnostic Test: "cardiac arrest" and "sudden death"

20-29 years age group

Diagnostic Test: "cardiac arrest" and "sudden death"

30-39 years age group

Diagnostic Test: "cardiac arrest" and "sudden death"

40 to 49 age group

Diagnostic Test: "cardiac arrest" and "sudden death"

50 to 59 age group

Diagnostic Test: "cardiac arrest" and "sudden death"

60 to 69 age group

Diagnostic Test: "cardiac arrest" and "sudden death"

70 to 79 age group

Diagnostic Test: "cardiac arrest" and "sudden death"

80+age group

Age group greater than or equal to 80 years

Diagnostic Test: "cardiac arrest" and "sudden death"

Interventions

Selection of cases with a secondary diagnosis containing the diagnostic keywords "cardiac arrest" and "sudden death"."cardiac arrest" and "sudden death".The incidence rate is then calculated

0-19 years age group20-29 years age group30-39 years age group40 to 49 age group50 to 59 age group60 to 69 age group70 to 79 age group80+age group

Eligibility Criteria

Age0 Years - 120 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Cases in the database with a secondary diagnosis containing the diagnostic keywords "cardiac arrest" and "sudden death".Data were collected from the GZ-EMS Command Centre's dispatch system database of pre-hospital data for the central urban districts of City.

You may qualify if:

  • Cases in the database with a secondary diagnosis containing the diagnostic keywords "cardiac arrest" and "sudden death"

You may not qualify if:

  • cases where the diagnosis of "cardiac arrest" and "sudden death" includes a diagnosis of a non-cardiac cause such as asphyxiation, suicide, drowning, advanced cancer, trauma, shock, poisoning, cerebral vascular accident, etc;
  • cases with duplicate records of sex, age, time of call, pick-up address and initial diagnosis

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Yu Tao

Guangdong, Guangdong, China

Location

MeSH Terms

Conditions

Heart ArrestDeath, Sudden, Cardiac

Condition Hierarchy (Ancestors)

Heart DiseasesCardiovascular DiseasesDeath, SuddenDeathPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Tao Yu

    Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, China

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 3, 2024

First Posted

June 7, 2024

Study Start

January 1, 2021

Primary Completion

December 31, 2025

Study Completion

December 31, 2025

Last Updated

June 7, 2024

Record last verified: 2023-12

Data Sharing

IPD Sharing
Will not share

Locations